Perthera AI

"With pivotal clinical trials for new cancer blood tests – so-called ‘liquid biopsies’ – occurring in 2022, transformative change for the diagnostics surrounding CRC may be around the corner."

Landmark year ahead for colorectal cancer testing and liquid biopsies March is National Colorectal Cancer (CRC) Awareness Month, a time aimed at raising awareness for what is the world’s second leading cause of cancer death worldwide. With pivotal clinical trials for new cancer blood tests – so-called ‘liquid biopsies’ – occurring in 2022, transformative cha...

3 Trends to Track in Health Care

Infographic: 3 Trends to Track in Health Care Avera is at the forefront of health care trends as we evolve everything from cancer treatments to 24/7 access. Watch these three trends in the coming years.

Gabe Kwong, Associate Professor at Georgia Tech and Emory University, and his team have developed a system of synthetic biosensors that will let a patient and doctor quickly learn if an ICB therapy is working through a non-invasive urinalysis.

Researchers develop a system of synthetic biosensors to assess the response of cancer therapy Immune checkpoint blockade (ICB) inhibitors have transformed the treatment of cancer and have become the frontline therapy for a broad range of malignancies. It's because they work better than the previous standard of care.